Back to Search Start Over

Development and validation of a model to predict complex Mohs micrographic surgery in clinical practice: REGESMOSH scale.

Authors :
Montero‐Vilchez, Trinidad
Garcés, Joan R.
Rodríguez‐Prieto, Manuel A.
Ruiz‐Salas, Verónica
de Eusebio‐Murillo, Esther
Miñano‐Medrano, Román
Escutia‐Muñoz, Begoña
González‐Sixto, Beatriz
Artola‐Igarza, Juan L.
Alfaro‐Rubio, Alberto
Redondo, Pedro
Delgado‐Jiménez, Yolanda
Sánchez‐Schmidt, Julia M.
Allende‐Markixana, Irati
Alonso‐Pacheco, María L.
García‐Bracamonte, Beatriz
de la Cueva‐Dobao, Pablo
Navarro‐Tejedor, Raquel
Ciudad‐Blanco, Cristina
Carnero‐González, Lucía
Source :
Journal of the European Academy of Dermatology & Venereology. Aug2023, Vol. 37 Issue 8, p1587-1594. 8p.
Publication Year :
2023

Abstract

Introduction: There is still a need to develop a simple algorithm to identify patients likely to need complex Mohs micrographic surgery (MMS) and optimize MMS schedule. The main objectives of this study are to identify factors associated with a complex MMS and develop a predictor model of the number of stages needed in surgery and the need for a complex closure. Materials and Methods: A nationwide prospective cohort study (REGESMOHS, the Spanish Mohs surgery registry) was conducted including all patients with a histological diagnosis of basal cell carcinoma (BCC). Factors related to three or more stages and a complex closure (that needing a flap and/or a graft) were explored and predictive models were constructed and validated to construct the REGESMOSH scale. Results: A total of 5226 patients that underwent MMS were included in the REGESMOHS registry, with 4402 (84%) having a histological diagnosis of BCC. A total of 3689 (88.9%) surgeries only needed one or two stages and 460 (11.1%) required three or more stages. A model to predict the need for three or more stages included tumour dimension, immunosuppression, recurrence, location in risk areas, histological aggressiveness and previous surgery. Regarding the closure type, 1616 (38.8%) surgeries were closed using a non‐complex closure technique and 2552 (61.2%) needed a complex closure. A model to predict the need for a complex closure included histological aggressiveness, evolution time, patient age, maximum tumour dimension and location. Conclusion: We present a model to predict MMS needing ≥3 stages and a complex closure based on epidemiological and clinical data validated in a large population (with real practice variability) including different centres that could be easily implemented in clinical practice. This model could be used to optimize surgery schedule and properly inform patients about the surgery duration. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
09269959
Volume :
37
Issue :
8
Database :
Academic Search Index
Journal :
Journal of the European Academy of Dermatology & Venereology
Publication Type :
Academic Journal
Accession number :
166735050
Full Text :
https://doi.org/10.1111/jdv.19056